Wednesday 16 May 2012

The New England Journal Of Medicine-Fda Analysis-Fosamax-Prweb

FDA Reports Fosamax May Not Help Women Long Term

According to the FDA analysis published on May 9th, 2012 in the New England Journal of Medicine, bone-strengthening drugs such as Fosamax may have little long-term benefit. Fosamax, manufactured by...(PRWeb May 15, 2012)Read the full story at (Source: PRWeb: Medical Pharmaceuticals)MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors read more..

No comments:

Post a Comment